Novartis to begin big arthritis trial
Novartis, the Swiss pharmaceuticals group, is launching the largest ever clinical trial of an arthritis treatment in an effort to prove its experiment drug, Prrexige, is better than existing
Novartis, the Swiss pharmaceuticals group, is launching the largest ever clinical trial of an arthritis treatment in an effort to prove its experiment drug, Prrexige, is better than existing